Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

ASR-490

ASR-490 reduces the viability of HCT116 and SW620 cells by downregulating Notch1 signaling. ASR-490 overcomes Notch1 overexpression and inhibits the growth of HCT/Notch1 transfectants. ASR-490 inhibits the tumor growth in control (pCMV/HCT116) and Notch1/HCT116 in xenotransplanted mice[1].

Product Specifications

CAS Number

[2690312-67-3]

UNSPSC

12352005

Target

Notch

Type

Reference compound

Related Pathways

Neuronal Signaling; Stem Cell/Wnt

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/asr-490.html

Purity

99.20

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

C[C@]([C@](CC[C@@]12C)([H])[C@@]([C@]1([H])CC[C@]2([H])[C@@H]([C@@](OC3=O)([H])CC(C)=C3CO)C)([H])C4)(C5=O)[C@@]6([C@H](C=C5)OC(C7=CC=CC=N7)=O)[C@]4([H])O6

Molecular Formula

C34H41NO7

Molecular Weight

575.69

References & Citations

[1]Tyagi A, et al. ASR490, a Small Molecule, Overrides Aberrant Expression of Notch1 in Colorectal Cancer. Mol Cancer Ther. 2020; 19 (12) :2422-2431.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

KDR (Kinase Insert Domain Receptor (a Type III Receptor Tyrosine Kinase), CD309, FLK1, VEGFR, VEGFR2) (HRP)
247839-HRP 100 µL

KDR (Kinase Insert Domain Receptor (a Type III Receptor Tyrosine Kinase), CD309, FLK1, VEGFR, VEGFR2) (HRP)

Ask
View Details
Human TEM5/GPR124 MAb (Clone 499716)
MAB8896-SP 25 µg

Human TEM5/GPR124 MAb (Clone 499716)

Ask
View Details
Shd (NM_001159523) Mouse Tagged ORF Clone Lentiviral Particle
MR217836L3V 200 µL

Shd (NM_001159523) Mouse Tagged ORF Clone Lentiviral Particle

Ask
View Details